NIO Shares Gain As June Deliveries Jump By Over 60% Reflecting Recovery
NIO Inc (NYSE: NIO) reported its June and sec
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.
Akerna Shares Dip 53%, Here’s 78 Biggest Movers From Yesterday
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.
Micron, Akebia Therapeutics And 3 Stocks To Watch Heading Into Friday
Some of the stocks that may grab investor focus today are:
Mike Novogratz Expects Bitcoin To ‘Explode North’ The Moment ‘Powell Pauses’
The cryptocurrency market is starting to show some signs of life after trending lower since peaking in late 2021.
Bank Of America And Wells Fargo May Slow Down On Weak Guidance, Analyst Says
Earnings season kicks off this week and many of the big banks are set to report quarterly financial results.
Earnings will probably be better-than-expected, but the outlook for net interest income is likely to be guided down, Morgan Stanley analyst Betsy Graseck said Monday on CNBC's "Squawk Box."
Elon Musk Dubs Dogecoin ‘People’s Crypto,’ Sending It Soaring 50% Again
Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk in a tweet early Monday said Dogecoin (DOGE) was “people’s crypto.”
5 Risks For Lululemon
Lululemon Athletica inc’s (NASDAQ: LULU) comps are likely to slow going ahead, Goldman Sachs’ Lindsay Drucker Mann said in a report. She maintained a Sell rating on the company, while reducing the price target from $48 to $46.
Freeport-McMoRan Bull Vs. Bear Battle: Upgraded At Citi, Downgraded At Bank Of America
Shares of Freeport-McMoRan Inc (NYSE: FCX) were trading higher Monday morning following mixed news as shares were upgraded at Citigroup and downgraded from analyst at Bank of America.
Can An Option Trading Strategy Known As ‘Maximum Pain Theory’ Make You Money?
The popularity of options trading has exploded in recent years, and some traders believe one strategy revolving around option expiration dates gives them a slight edge in the market.